Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma to the ALK inhibitor ceritinib

Ruth Palmer
Ruth Palmer
Professor at Department of Biochemistry and Cell Biology

I want to impart those around me with my enthusiasm for research and to train the next generation scientist.